Vanda Pharmaceuticals (VNDA) EPS (Basic) Growth (1y) (2011 - 2026)
Vanda Pharmaceuticals (VNDA) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -61.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -61.94% |
| Dec 31, 2025 | -2,757.17% |
| Sep 30, 2025 | -316.78% |
| Jun 30, 2025 | -493.86% |
| Mar 31, 2025 | -602.06% |
| Dec 31, 2024 | -101.24% |
| Sep 30, 2024 | -3,950.99% |
| Jun 30, 2024 | -398.83% |
| Mar 31, 2024 | -226.77% |
| Dec 31, 2023 | -134.29% |
| Sep 30, 2023 | -95.87% |
| Jun 30, 2023 | -43.34% |
| Mar 31, 2023 | 149.14% |
| Dec 31, 2022 | -4.63% |
| Sep 30, 2022 | -58.45% |
| Jun 30, 2022 | -73.61% |
| Mar 31, 2022 | -173.45% |
| Dec 31, 2021 | -15.49% |
| Sep 30, 2021 | 27.51% |
| Jun 30, 2021 | 8.93% |